Hantavirus outbreak on cruise ship kills three, sparks CDC funding debate

An outbreak of hantavirus on an international cruise ship has left three people dead and at least eight others ill. The incident has sparked criticism from U.S. Senator Chuck Schumer, who warned that cuts to public health programs have weakened the country’s ability to respond to such threats.

The MV Hondius, where the Andes strain of hantavirus spread, has now begun returning passengers to their home countries, including seven Americans who arrived back in the U.S. The outbreak occurred aboard the MV Hondius, where the deadly Andes strain of hantavirus infected multiple passengers. So far, three have died, and eight more have fallen seriously ill.

Last year, the Trump administration eliminated the CDC’s full-time Vessel Sanitation Program staff, reducing oversight of cruise ship health standards. Schumer argued that these cuts directly contributed to the current crisis, leaving gaps in disease surveillance and response.

In a statement, Schumer demanded answers about the federal government’s handling of the outbreak. He also called for the immediate rehiring of CDC cruise ship inspectors and Port Health Station staff who were laid off during budget reductions.

Beyond restoring CDC staffing, Schumer urged the White House to reverse broader funding cuts. He pushed for reinvestment in infectious disease research, vaccine development, and global viral threat monitoring. Additionally, he called on the administration to rejoin the World Health Organization, which it left in 2020.

Passengers from the affected ship have now started disembarking, with seven Americans already returning to the U.S. Others are heading to their respective countries as health officials continue to assess the situation. The hantavirus outbreak has raised concerns about the impact of reduced CDC resources on public health safety. Schumer’s demands include reinstating funding for disease prevention and rehiring key personnel to prevent future crises. The incident also highlights ongoing debates over the U.S. role in global health organisations.